Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evolution of CCR5 Antagonist Resistance in an HIV-1 Subtype C Clinical Isolate

Published:2010-12-01 Issue:4 Volume:55 Page:420-427
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Henrich Timothy J,Tsibris Athe M N,Lewine Nicolas R P,Konstantinidis Ioannis,Leopold Kay E,Sagar Manish,Kuritzkes Daniel R

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference40 articles.

1. Chemokine antagonists as therapeutics: focus on HIV-1.;Tsibris;Annu Rev Med,2007

2. Maraviroc for previously treated patients with R5 HIV-1 infection.;Gulick;N Engl J Med,2008

3. Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor, in HIV-1-Infected, treatment-experienced patients: AIDS clinical trials group 5211.;Gulick;J Infect Dis,2007

4. Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection.;Landovitz;J Infect Dis,2008

5. Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1.;Strizki;Antimicrob Agents Chemother,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CB‐0821, a novel CC chemokine receptor 5 (CCR5) inhibitor with improved binding efficacy proposed as anti‐HIV candidate: Computational and in vitro approach;Biotechnology and Applied Biochemistry;2024-03-31

2. Evolution of Multiple Domains of the HIV-1 Envelope Glycoprotein during Coreceptor Switch with CCR5 Antagonist Therapy;Microbiology Spectrum;2022-08-31

3. V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist Resistance;Journal of Virology;2019-05

4. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher?;Biochemical Journal;2017-04-26

5. HIV-1 Entry Inhibitor Resistance;Handbook of Antimicrobial Resistance;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3